PCK2 Inhibition Reverses Cisplatin Resistance of Non-Small Cell Lung Cancer by Triggering Ferroptosis.
- DOI
- 10.1096/fj.202602464r
- Published
- 2026 Aug 31
- Container
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1096/fj.202602464r,
title = {PCK2 Inhibition Reverses Cisplatin Resistance of Non-Small Cell Lung Cancer by Triggering Ferroptosis.},
author = {Liu J and Wang Z and Gu C and Chen Y and Yang Y and Zhu J and Zhang Y and Shao Y and Pang X and Ge Y and Qian H and Huang JA and Liu Z and Zeng Y and Ji C},
year = {2026},
journal = {FASEB journal : official publication of the Federation of American Societies for Experimental Biology},
doi = {10.1096/fj.202602464r},
url = {https://doi.org/10.1096/fj.202602464r}
}RIS
TY - JOUR TI - PCK2 Inhibition Reverses Cisplatin Resistance of Non-Small Cell Lung Cancer by Triggering Ferroptosis. AU - Liu J AU - Wang Z AU - Gu C AU - Chen Y AU - Yang Y AU - Zhu J AU - Zhang Y AU - Shao Y AU - Pang X AU - Ge Y AU - Qian H AU - Huang JA AU - Liu Z AU - Zeng Y AU - Ji C PY - 2026 JO - FASEB journal : official publication of the Federation of American Societies for Experimental Biology DO - 10.1096/fj.202602464r UR - https://doi.org/10.1096/fj.202602464r ER -
APA
J, L., Z, W., C, G., Y, C., Y, Y., J, Z., Y, Z., Y, S., X, P., Y, G., H, Q., JA, H., Z, L., Y, Z., & C, J. (2026). PCK2 Inhibition Reverses Cisplatin Resistance of Non-Small Cell Lung Cancer by Triggering Ferroptosis.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. https://doi.org/10.1096/fj.202602464r
Source records
- pubmed · retrieved 2026-09-26T16:27:21.247Z